Abstract
FRβ constitutes a unique and selective marker for activated human monocytes and macrophages. Based on numerous criteria, most FR+ macrophages appear to be highly inflammatory and important in the development/maintenance of many inflammatory and autoimmune diseases, however, some appear to be activated and anti-inflammatory. Inflammatory pathologies in which FR+ macrophages are commonly enriched include rheumatoid arthritis, Crohn’s disease, atherosclerosis, sarcoidosis, glomerulonephritis, osteoarthritis, organ transplant rejection, ulcerative colitis, Sjogren’s syndrome, diabetes, ischemia/reperfusion injury, impact trauma, microbial infection, prosthesis osteolysis, liver steatosis, and multiple sclerosis. Folate-targeted imaging agents have proven useful in identifying, localizing, and quantifying sites of inflammation in both human patients and animal models of the above diseases. Folate-targeted therapeutic agents offer great promise for the development of highly potent, nontoxic treatment modalities for the same diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Antohe F, Radulescu L, Puchianu E et al (2005) Increased uptake of folate conjugates by activated macrophages in experimental hyperlipemia. Cell Tissue Res 320:277–285
Antony A (1992) The biological chemistry of folate receptors. Blood 79:2807–2820
Ayala-López W, Xia W, Varghese B et al (2010) Imaging of atherosclerosis in apoE-/- mice: targeting of a folate-conjugated radiopharmaceutical to activated macrophages. J Nucl Med 51:768–774
Benoit M, Desnues B, Mege J (2008) Macrophage polarization in bacterial infections. J Immunol 181:3733–3739
Bobryshev Y (2006) Monocyte recruitment and foam cell formation in atherosclerosis. Micron 37:208–222
Bresnihan B (1999) Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatol 26:717–719
Buechler C, Ritter M, Orso E et al (2000) Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro-inflammatory and anti-inflammatory stimuli. J Leukoc Biol 67:97–103
Chen W, Khazaie K, Zhang G et al (2005a) Detection of dysplastic intestinal adenomas using a fluorescent folate imaging probe. Mol Imaging 4:67–74
Chen W, Mahmood U, Weissleder R et al (2005b) Arthritis imaging using a near-infrared fluorescence folate-targeted probe. Arthritis Res Ther 7:R310–R317
Dragun D, Hoff U, Park J et al (2000) Ischemia reperfusion injury in renal transplantation is independent of the immunologic background. Kidney Int 58:2166–2177
Elnakat H, Ratnam M (2004) Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy. Adv Drug Deliv Rev 56:1067–1084
Foster M, Kelley V (1999) Lupus nephritis: update on pathogenesis and disease mechanisms. Semin Nephrol 19:173–181
Fuentes-Duculan J, Suarez-Farinas M, Zaba L et al (2010) A subpopulation of CD163 positive macrophages is classically activated in psoriasis. J Invest Dermatol 130(10):2412–2422
Furth R, Cohn Z (1968) The origin and kinetics of mononuclear phagocytes. J Exp Med 128:415–435
Geissmann F, Manz MG (2010) Development of monocytes, macrophages, and dendritic cells. Science 327:656–661
Gordon S (2003a) Alternative activation of macrophages. Nat Rev Immunol 3:23–35
Gordon S (2003b) Macrophages and the immune response. In: Paul W (ed) Fundamental immunology. William & Wilkins, Philadelphia, PA
Gordon S, Taylor P (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953–964
Gueler F, Park J, Rong S et al (2007) Statins attenuate ischemia-reperfusion injury by inducing heme oxygenase-1 in infiltrating macrophages. Am J Pathol 170:1192–1199
Heijden J, Oerlemans R, Dijkmans B et al (2009) Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients. Arthritis Rheum 60:12–21
Khazen W, M’Bika J, Tomkiewicz C et al (2005) Expression of macrophage-selective markers in human and rodent adipocytes. FEBS Lett 579:5631–5634
Kim Y (2005) Nutritional epigenetics: impact of folate deficiency on DNA methylation and colon cancer susceptibility. J Nutr 135:2703–2709
Kinne R, Brauer R, Stuhlmuller B et al (2000) Macrophages in rheumatoid arthritis. Arthritis Res 2:189–202
Leamon C, Jackman A (2008) Exploitation of the folate receptor in the management of cancer and inflammatory disease. Vitam Horm 79:203–233
Loenen W (2006) S-adenosylmethionine: jack of all trades and master of everything? Biochem Soc Trans 34:330–333
Low P, Henne W, Doorneweerd D (2008) Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res 41:120–129
Lumeng C, Bodzin J, Saltiel A (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117(1):175–184
Martinez F, Helming L, Gordon S (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27:451–483
Matherly L, Goldman D (2003) Membrane transport of folates. Vitam Horm 66:403–456
Matteson E, Lowe V, Prendergast F et al (2009) Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical Folatescan. Clin Exp Rheumatol 27:253–259
Nagai T, Tanaka M, Tsuneyoshi Y et al (2006) In vitro and in vivo efficacy of a recombinant immunotoxin against folate receptor beta on the activation and proliferation of rheumatoid arthritis synovial cells. Arthritis Rheum 54:3126–3134
Nagai T, Tanaka M, Tsuneyoshi Y et al (2009) Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor beta. Cancer Immunol Immunother 58:1577–1586
Nagayoshi R, Nagai T, Matsushita K et al (2005) Effectiveness of anti-folate receptor beta antibody conjugated with truncated Pseudomonas exotoxin in the targeting of rheumatoid arthritis synovial macrophages. Arthritis Rheum 52:2666–2675
Nakashima-Matsushita N, Homma T, Yu S et al (1999) Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. Arthritis Rheum 42:1609–1616
Odegaard J, Ricardo-Gonzalez R, Goforth M et al (2007) Macrophage-specific PPAR gamma controls alternative activation and improves insulin resistance. Nature 447:1116–1120
Parker N, Turk M, Westrick E et al (2005) Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 338:284–293
Patsouris D, Li P, Thapar D et al (2008) Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 8(4):301–309
Paulos C, Turk M, Breur G et al (2004) Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv Drug Deliv Rev 56:1205–1217
Paulos C, Varghese B, Widmer W et al (2006) Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis. Arthritis Res Ther 8:R77
Porcheray F, Viaud S, Rimaniol A et al (2005) Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 143(3):481–489
Puig-Kroger A, Sierra-Filardi E, Dominguez-Soto A et al (2009) Folate receptor β is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages. Cancer Res 69:9395–9403
Reddy J, Haneline L, Srour E et al (1999) Expression and functional characterization of the beta-isoform of the folate receptor on CD34(+) cells. Blood 93:3940–3948
Ren Y, Tang J, Mok M et al (2003) Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum 48:2888–2897
Ross J, Chaudhuri P, Ratnam M (1994) Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Cancer 73:2432–2443
Ross J, Wang H, Behm F et al (1999) Folate receptor type β is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia. Cancer 85:348–357
Saborowski O, Simon G, Raatschen H et al (2007) MR imaging of antigen-induced arthritis with a new, folate receptor-targeted contrast agent. Contrast Media Mol Imaging 2:72–81
Salazar M, Ratnam M (2007) The folate receptor: what does it promise in tissue-targeted therapeutics? Cancer Mestastasis Rev 26:141–152
Sandoval R, Kennedy M, Low P et al (2004) Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy. Am J Physiol Cell Physiol 287:C517–C526
Stout R, Suttles J (2004) Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 76:509–513
Swirski F, Libby P, Aikawa E et al (2007) Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 117:195–205
Turk M, Breur G, Widmer W et al (2002) Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis. Arthritis Rheum 46:1947–1955
Turk M, Waters D, Low P (2004) Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma. Cancer Lett 213:165–172
Varghese B, Haase N, Low P (2007) Depletion of folate-receptor-positive macrophages leads to alleviation of symptoms and prolonged survival in two murine models of systemic lupus erythematosus. Mol Pharm 4:679–685
Varghese B, Paulos C, Low P (in press) Optimization of folate-targeted immunotherapy for treatment of experimental arthritis. Scand J Rheumatol
Wang H, Peters T, Kess D et al (2006) Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. J Clin Invest 116:2105–2114
Weitman S, Weinberg A, Coney L et al (1992) Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. Cancer Res 52:6708–6711
Xia W, Hilgenbrink A, Matteson E et al (2009) A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood 113:438–446
Yi Y, Ayala-Lopez W, Kularatne S et al (2009) Folate-targeted hapten immunotherapy of adjuvant-induced arthritis: comparison of hapten potencies. Mol Pharm 6:1228–1236
Zeyda M, Farmer D, Todoric J et al (2007) Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes 31:1420–1428
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Hansen, M.J., Low, P.S. (2011). Folate Receptor Positive Macrophages: Cellular Targets for Imaging and Therapy of Inflammatory and Autoimmune Diseases. In: Jackman, A., Leamon, C. (eds) Targeted Drug Strategies for Cancer and Inflammation. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8417-3_9
Download citation
DOI: https://doi.org/10.1007/978-1-4419-8417-3_9
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-8416-6
Online ISBN: 978-1-4419-8417-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)